Grifols SA (GRFS)
8.24
-0.01
(-0.12%)
USD |
NASDAQ |
Apr 02, 16:00
8.245
0.00 (0.00%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly) : 0.168 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Akari Therapeutics Plc | 0.00 |
| DBV Technologies SA | -1.170 |
| Cellectis SA | -0.2621 |
| Pharma Mar SA | 3.978 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 146.39M |
| Revenue (Quarterly) | 2.307B |
| Total Expenses (Quarterly) | 2.192B |
| Enterprise Value | 17.65B |
| Gross Profit Margin (Quarterly) | 34.66% |
| Profit Margin (Quarterly) | 6.35% |
| Earnings Yield | 8.18% |
| Operating Earnings Yield | 25.27% |
| Normalized Earnings Yield | 7.815 |